🕵️ Celldex Therapeutics, Inc. ($CLDX)
SEC insider & ownership activity, last 12 months · CIK 744218 · every row links its SEC filing
Over the last 12 months insiders sold $1.3M with no open-market buying against it. Richard M. Wright sold $1.2M in discretionary trades (Nov). BlackRock, Inc. trimmed 8.3% → 7.3%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $1.3M (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Richard M. Wright | 0 | – | 1 | $1.2M | Nov 13, 2025 |
| Freddy A. Jimenez | 0 | – | 1 | $121K | Dec 4, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 12.2% | 13G | Feb 10, 2026 | filing ↗ | |
| Wellington Group Holdings LLP | 12.2% | 13G | Feb 10, 2026 | filing ↗ | |
| Wellington Investment Advisors Holdings LLP | 12.2% | 13G | Feb 10, 2026 | filing ↗ | |
| Wellington Management Company LLP | 11.8% | 13G | Feb 10, 2026 | filing ↗ | |
| BlackRock, Inc. | 7.3% | 13G | Apr 17, 2025 | filing ↗ | |
| Kynam Capital Management, LP | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Kynam Capital Management GP, LLC | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Yue Tang | 6.8% | 13G | Aug 14, 2026 | filing ↗ | |
| T. ROWE Price Associates, Inc. | 6.0% | 13G | Aug 14, 2026 | filing ↗ | |
| FMR LLC | 5.6% | 13G | May 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 5.6% | 13G | May 6, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing ↗ | |
| Commodore Capital LP | 5.0% | 13G | Apr 10, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Freddy A. Jimenez | $121K | Dec 4, 2025 | filing ↗ |
| Richard M. Wright | $1.2M | Nov 13, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 25, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 1, 2026 | filing ↗ |
| Other events (8.01) | Apr 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 1, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |